[EN] SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS [FR] PYRAZOLOAZÉPIN-8-ONES SUBSTITUÉES, ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTÉRASE
[EN] SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS [FR] PYRAZOLOAZÉPIN-8-ONES SUBSTITUÉES, ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTÉRASE
Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors
申请人:LEO Pharma A/S
公开号:US10793580B2
公开(公告)日:2020-10-06
The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
申请人:Leo Pharma A/S
公开号:EP3551634B1
公开(公告)日:2021-03-31
Nucleophilic Organosilicon Intermediates Turned Electrophilic: (Trimethylsilyl)methyl, Trimethylsilyloxy and also 2-Tetrahydropyranyloxy as Terminators of Cycloadditions of Allyl Cations. A Short Route to Dehydrozizaenes (6-Methylenetricyclo[6.2.1.01,5]-undec-9,10-enes) and Related Tricycles and [3.2.1]-Bicycles.
[EN] SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS<br/>[FR] PYRAZOLOAZÉPIN-8-ONES SUBSTITUÉES, ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTÉRASE
申请人:LEO PHARMA AS
公开号:WO2018108231A1
公开(公告)日:2018-06-21
The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.